))
Episode 13 - The Journey of a HealthTech Start-up with Dr Hemmel Amrania
Manage episode 445729484 series 3609046
Innehåll tillhandahållet av BioTalent Social. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av BioTalent Social eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Dr. Hemmel Amrania YC21 is the founder of Digistain. A platform cancer diagnostics technology that promises to eliminate the overuse of cytotoxic chemotherapy. He is a world-leading expert in infrared imaging. He holds the degrees of MSc and PhD in Physics from SupOptique, Paris, and Imperial College London, where his work as a Post Doctorate Researcher in the field of laser-based medical imaging saw him file for 7 patents and receive the Imperial College's Outstanding Research Prize as well as the Royal Society Innovation Award for his contribution to breast cancer imaging. He spear-headed Digistain's R&D from its beginnings in a physics lab, securing both public and private funding for clinical trials all the way to clinical deployment. Hemmel’s specialities include Quantum Detection, Microscopic Optics, Infra-red, Laser, Multispectral, and Chemical Imaging on which he is the contributor for the book Vibrational Spectroscopy for Biomedical Applications. His cutting-edge achievements also include two world firsts in the demonstrations of live cell chemical imaging using a benchtop device and intermediate band-gap solid-state solar cells.
21 episoder
Dela
